Advertisement Organetix completes $310,000 private placement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Organetix completes $310,000 private placement

Organetix has completed a $310,000 equity private placement financing. Proceeds from this private placement will be used to complete the pending transaction with Florida-based Seafarer Exploration.

Under terms of the previously executed memorandum of understanding (MOU) with Seafarer, Organetix is required to contribute a minimum of $150,000 and a maximum of $600,000 to the combined company. The final percentage ownerships of the combined company, will vary based upon the amount of cash contributed by Organetix shareholders.

Seth Shaw, CEO of Organetix, said: “This private placement enables Organetix to complete the pending transaction with Seafarer, under terms of the MOU. Both managements are working productively towards the execution of a definitive share exchange agreement.”